Clinical trial
Double-blind, Three Parallel Randomized Groups, Therapeutic Confirmatory Clinical Trial to Compare the Efficacy of Oral Levocetirizine 5 mg and Montelukast 10 mg to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Ragweed Sensitive Subjects Exposed to Ragweed Pollen in an Environmental Exposure Unit (EEU)
NCT00295022 is registered in ClinicalTrials.gov with UCB S.A. - Pharma Sector as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind, Three Parallel Randomized Groups, Therapeutic Confirmatory Clinical Trial to Compare the Efficacy of Oral Levocetirizine 5 mg and Montelukast 10 mg to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Ragweed Sensitive Subjects Exposed to Ragweed Pollen in an Environmental Exposure Unit (EEU)
- Lead sponsor
- UCB S.A. - Pharma Sector
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 29, 2006
- Completion date
- October 1, 2006
- Enrollment
- 418 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.